IPO registrations (S-1, F-1) · Registrants
ATOSSA THERAPEUTICS, INC.
- SEC CIK
- 1488039 · filings on EDGAR ↗
- Former names
- ATOSSA GENETICS INC (2010–2019)
- Registration
- Form S-1, first filed 2010-03-30, last 2020-12-01; 13 initial registrations, 28 amendments
- Outcome
- Final prospectus filed 2012-11-09; declared effective 2012-11-07; withdrawal requested 2010-07-28
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- DE
- Business address
- 1448 NW MARKET STREET, SUITE 500, Seattle, WA 98107
- EIN
- 26-4753208
- Ticker
- ATOS (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- ATOSSA THERAPEUTICS, INC. on the corporate pages
On this site
- Business registration: ATOSSA GENETICS INC. EXACT (EIN (EXACT, as the state registration reports it))
- Form 5500 plan sponsor: ATOSSA THERAPEUTICS, INC. EXACT (EIN (EXACT))
- Lobbying client: ATOSSA THERAPEUTICS, INC. Fuzzy (name and state)
- SEC filer: ATOSSA GENETICS INC EXACT (CIK (EXACT))
Filings 64
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2010-03-30 | S-1 | S-1 (registration) | ATOSSA GENETICS INC | 0001144204-10-016530 ↗ |
| 2010-07-28 | RW | RW (withdrawal request) | ATOSSA GENETICS INC | 0001144204-10-039594 ↗ |
| 2010-10-01 | S-1 | S-1 (registration) | ATOSSA GENETICS INC | 0001144204-10-051825 ↗ |
| 2010-11-23 | S-1/A | S-1/A (amendment) | ATOSSA GENETICS INC | 0001144204-10-063028 ↗ |
| 2010-12-16 | S-1/A | S-1/A (amendment) | ATOSSA GENETICS INC | 0001144204-10-066740 ↗ |
| 2011-01-10 | S-1/A | S-1/A (amendment) | ATOSSA GENETICS INC | 0001144204-11-001397 ↗ |
| 2011-02-04 | S-1/A | S-1/A (amendment) | ATOSSA GENETICS INC | 0001144204-11-006053 ↗ |
| 2011-02-15 | RW | RW (withdrawal request) | ATOSSA GENETICS INC | 0001144204-11-008734 ↗ |
| 2012-02-14 | S-1 | S-1 (registration) | ATOSSA GENETICS INC | 0001144204-12-007893 ↗ |
| 2012-04-06 | S-1/A | S-1/A (amendment) | ATOSSA GENETICS INC | 0001144204-12-020447 ↗ |
| 2012-05-21 | S-1/A | S-1/A (amendment) | ATOSSA GENETICS INC | 0001144204-12-030728 ↗ |
| 2012-06-11 | S-1/A | S-1/A (amendment) | ATOSSA GENETICS INC | 0001144204-12-034079 ↗ |
| 2012-06-18 | S-1/A | S-1/A (amendment) | ATOSSA GENETICS INC | 0001144204-12-035151 ↗ |
| 2012-06-25 | S-1/A | S-1/A (amendment) | ATOSSA GENETICS INC | 0001144204-12-036238 ↗ |
| 2012-08-13 | S-1/A | S-1/A (amendment) | ATOSSA GENETICS INC | 0001144204-12-044528 ↗ |
| 2012-08-21 | S-1/A | S-1/A (amendment) | ATOSSA GENETICS INC | 0001144204-12-047228 ↗ |
| 2012-08-30 | S-1/A | S-1/A (amendment) | ATOSSA GENETICS INC | 0001144204-12-049048 ↗ |
| 2012-10-04 | S-1/A | S-1/A (amendment) | ATOSSA GENETICS INC | 0001144204-12-054574 ↗ |
| 2012-10-19 | S-1/A | S-1/A (amendment) | ATOSSA GENETICS INC | 0001144204-12-056912 ↗ |
| 2012-10-25 | S-1/A | S-1/A (amendment) | ATOSSA GENETICS INC | 0001144204-12-057756 ↗ |
| 2012-11-06 | S-1/A | S-1/A (amendment) | ATOSSA GENETICS INC | 0001144204-12-059531 ↗ |
| 2012-11-07 | EFFECT | EFFECT (declared effective) | ATOSSA GENETICS INC | 9999999995-12-003176 ↗ |
| 2012-11-09 | 424B4 | 424B4 (final prospectus) | ATOSSA GENETICS INC | 0001144204-12-061002 ↗ |
| 2013-01-28 | S-1 | S-1 (registration) | ATOSSA GENETICS INC | 0001144204-13-004258 ↗ |
| 2013-02-06 | S-1/A | S-1/A (amendment) | ATOSSA GENETICS INC | 0001144204-13-006291 ↗ |
| 2013-04-05 | S-1 | S-1 (registration) | ATOSSA GENETICS INC | 0001144204-13-020402 ↗ |
| 2013-04-16 | EFFECT | EFFECT (declared effective) | ATOSSA GENETICS INC | 9999999995-13-001025 ↗ |
| 2013-04-17 | S-1/A | S-1/A (amendment) | ATOSSA GENETICS INC | 0001144204-13-022365 ↗ |
| 2013-04-23 | EFFECT | EFFECT (declared effective) | ATOSSA GENETICS INC | 9999999995-13-001110 ↗ |
| 2013-11-12 | S-1 | S-1 (registration) | ATOSSA GENETICS INC | 0001144204-13-060623 ↗ |
| 2013-11-29 | EFFECT | EFFECT (declared effective) | ATOSSA GENETICS INC | 9999999995-13-003404 ↗ |
| 2013-12-11 | S-1/A | S-1/A (amendment) | ATOSSA GENETICS INC | 0001144204-13-066715 ↗ |
| 2013-12-13 | EFFECT | EFFECT (declared effective) | ATOSSA GENETICS INC | 9999999995-13-003560 ↗ |
| 2014-04-21 | EFFECT | EFFECT (declared effective) | ATOSSA GENETICS INC | 9999999995-14-001062 ↗ |
| 2014-04-25 | EFFECT | EFFECT (declared effective) | ATOSSA GENETICS INC | 9999999995-14-001124 ↗ |
| 2015-05-08 | EFFECT | EFFECT (declared effective) | ATOSSA GENETICS INC | 9999999995-15-001270 ↗ |
| 2015-06-26 | S-1 | S-1 (registration) | ATOSSA GENETICS INC | 0001144204-15-039460 ↗ |
| 2015-07-08 | EFFECT | EFFECT (declared effective) | ATOSSA GENETICS INC | 9999999995-15-001868 ↗ |
| 2015-11-27 | S-1 | S-1 (registration) | ATOSSA GENETICS INC | 0001144204-15-068300 ↗ |
| 2015-12-16 | S-1/A | S-1/A (amendment) | ATOSSA GENETICS INC | 0001144204-15-071226 ↗ |
| 2015-12-16 | EFFECT | EFFECT (declared effective) | ATOSSA GENETICS INC | 9999999995-15-003298 ↗ |
| 2016-06-03 | S-1 | S-1 (registration) | ATOSSA GENETICS INC | 0001144204-16-106624 ↗ |
| 2016-06-15 | EFFECT | EFFECT (declared effective) | ATOSSA GENETICS INC | 9999999995-16-004911 ↗ |
| 2017-02-13 | S-1 | S-1 (registration) | ATOSSA GENETICS INC | 0001144204-17-007884 ↗ |
| 2017-03-16 | S-1/A | S-1/A (amendment) | ATOSSA GENETICS INC | 0001615774-17-001094 ↗ |
| 2017-03-21 | S-1/A | S-1/A (amendment) | ATOSSA GENETICS INC | 0001615774-17-001159 ↗ |
| 2017-03-23 | S-1/A | S-1/A (amendment) | ATOSSA GENETICS INC | 0001615774-17-001190 ↗ |
| 2017-03-28 | S-1/A | S-1/A (amendment) | ATOSSA GENETICS INC | 0001615774-17-001273 ↗ |
| 2017-03-28 | S-1/A | S-1/A (amendment) | ATOSSA GENETICS INC | 0001615774-17-001284 ↗ |
| 2017-03-28 | EFFECT | EFFECT (declared effective) | ATOSSA GENETICS INC | 9999999995-17-000676 ↗ |
| 2017-10-05 | EFFECT | EFFECT (declared effective) | ATOSSA GENETICS INC | 9999999995-17-002602 ↗ |
| 2018-03-27 | S-1 | S-1 (registration) | ATOSSA GENETICS INC | 0001615774-18-002120 ↗ |
| 2018-04-23 | S-1/A | S-1/A (amendment) | ATOSSA GENETICS INC | 0001615774-18-002813 ↗ |
| 2018-05-03 | S-1/A | S-1/A (amendment) | ATOSSA GENETICS INC | 0001615774-18-003227 ↗ |
| 2018-05-09 | EFFECT | EFFECT (declared effective) | ATOSSA GENETICS INC | 9999999995-18-001185 ↗ |
| 2018-05-10 | 424B4 | 424B4 (final prospectus) | ATOSSA GENETICS INC | 0001615774-18-003583 ↗ |
| 2018-06-04 | S-1 | S-1 (registration) | ATOSSA GENETICS INC | 0001615774-18-004829 ↗ |
| 2018-06-14 | EFFECT | EFFECT (declared effective) | ATOSSA GENETICS INC | 9999999995-18-001509 ↗ |
| 2020-09-10 | EFFECT | EFFECT (declared effective) | ATOSSA THERAPEUTICS, INC. | 9999999995-20-002415 ↗ |
| 2020-11-20 | S-1 | S-1 (registration) | ATOSSA THERAPEUTICS, INC. | 0001437749-20-024290 ↗ |
| 2020-12-01 | S-1/A | S-1/A (amendment) | ATOSSA THERAPEUTICS, INC. | 0001437749-20-024667 ↗ |
| 2020-12-08 | EFFECT | EFFECT (declared effective) | ATOSSA THERAPEUTICS, INC. | 9999999995-20-003444 ↗ |
| 2021-01-29 | EFFECT | EFFECT (declared effective) | ATOSSA THERAPEUTICS, INC. | 9999999995-21-000358 ↗ |
| 2021-04-29 | EFFECT | EFFECT (declared effective) | ATOSSA THERAPEUTICS, INC. | 9999999995-21-001636 ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Barnhart John | Director | 2 | 2012–2013 | ||
| Benjamin Christopher | Officer | Chief Financial Officer | 1 | 2012 | |
| Chen Shu-Chih | Director; Director,Officer,TenPercentOwner; Director,TenPercentOwner | Chief Scientific Officer; CSO | 20 | 2012–2026 | |
| CROSS ALEXANDER D | Director | 3 | 2012–2013 | ||
| Galli Stephen J | Director | 15 | 2012–2026 | ||
| QUAY STEVEN C | Director,Officer; Director,Officer,TenPercentOwner | CEO; Chief Executive Officer; President and CEO; President & CEO | 25 | 2012–2026 | |
| Remmel H. Lawrence | Director | 19 | 2012–2026 | ||
| Guse Kyle | Officer | CFO, Gen Counsel and Secretary; CFO & General Counsel; See Remarks | 15 | 2013–2023 | |
| WEAVER GREGORY L | Director; Director,Officer | EVP & CFO; Former EVP, CFO, & Director | 17 | 2013–2023 | |
| Steinhart Richard I | Director | 15 | 2014–2026 | ||
| Chen Ben R | Officer | Sr. VP of Glob. Reg. Affairs; Sr. VP of Glob. Reg. Affairs | 2 | 2014 | |
| Carbonaro Peter J. | Officer | Sr. Vice President, Operations | 2 | 2014 | |
| Destro Christopher S. | Officer | Sr. VP, Sales and Marketing; SVP, Sales and Marketing | 3 | 2014–2015 | |
| Sawyer John E | Officer | See Remarks; Senior Vice President | 2 | 2014–2015 | |
| Youmans Scott | Officer | Chief Operating Officer | 2 | 2015 | |
| Rees Heather | Officer | Chief Financial Officer; SVP, Finance and Accounting | 3 | 2023–2025 | |
| Finn Jonathan | Director | 7 | 2023–2026 | ||
| Cigler Tessa | Director | 5 | 2024–2026 | ||
| Daniel Mark James | Officer | Chief Financial Officer | 3 | 2025–2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.